Marie Bentivegna
Women's Health · Willingboro, NJNPI 1639232671
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 143 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 24 manufacturers reported payments, led by AbbVie at 29.2% of the total. Reporting peaked in 2023 at $609 and has fallen 85.0% since, to $91 in 2025. Among women's health clinicians in NJ with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 143 payments — averaging $13.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$562
- Mayne Pharma Commercial LLC$202
- Pfizer$170
- Evofem Biosciences, Inc.$161
- Sumitomo Pharma America, Inc.$150
- Astellas Pharma US Inc$77
- plus $601 from 18 others
What the payments were for
- Food & beverage$1,923100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 51 | $562 |
| Mayne Pharma Commercial LLC | 24 | $202 |
| Pfizer | 10 | $170 |
| Evofem Biosciences, Inc. | 10 | $161 |
| Sumitomo Pharma America, Inc. | 9 | $150 |
| Astellas Pharma US Inc | 4 | $77 |
| Exeltis, USA Inc. | 3 | $72 |
| Amgen | 5 | $70 |
| Mylan Pharmaceuticals Inc. | 4 | $64 |
| Agile Therapeutics, Inc. | 4 | $58 |
| Shield Therapeutics Inc | 2 | $58 |
| Myovant Sciences Inc. | 3 | $43 |
| Bayer | 2 | $30 |
| Scynexis, Inc. | 2 | $28 |
| Convatec Inc. | 1 | $25 |
| Hologic Sales And Service, LLC | 1 | $24 |
| Sage Therapeutics, LLC | 1 | $20 |
| Coopersurgical, Inc. | 1 | $18 |
| Millicent US Inc | 1 | $17 |
| Merck | 1 | $15 |
| Therapeuticsmd, Inc. | 1 | $15 |
| Dysis Medical, Inc. | 1 | $14 |
| Medicem Inc. | 1 | $14 |
| Avion Pharmaceuticals | 1 | $14 |
How this compares
$1,923 in reported general payments places this provider in the 90th percentile of 182 women's health providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 29 | $1,120 |
| ValacyclovirValacyclovir Hcl | 16 | $440 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 14 | $208 |
| Metronidazole | 12 | $186 |
Paid to pharmacies, not to this prescriber.
Other women's health in Willingboro
- Dorothy StrikeyWillingboro$2K
- Dolores FeeWillingboro$1K
- Jennifer UmekWillingboro$464
- Kathie OlsonLawrenceville$5K
- Valerie FultonPennsauken$5K
- Patience AssobmoNewark$5K
- Lorraine HarrisPennsauken$4K
- Edita LuansingRidgewood$4K
- Seton CiagliaOradell$3K
- Kelsey DenningToms River$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.